VIVOZON
Vivozon is working to extend its pipeline of second generation analgesic medication candidates, as well as its target combination of third analgesic drug opportunities. Vivozon creates new chemical medications with synergistic efficacy by acting on several targets. People derive candidate substances with potential for successful phase 2 clinical trials by applying efficacy based screening from the early stages of discovery, and they continue with global clinical development clinical trials as ... a single dose injectable for treating postoperative pain, which will be expanded to various indications such as neuropathic pain and cancer pain by multiple administration routes makes bold funding for research and education, developing its pipeline to include treatments for central nervous system illnesses like addiction, dementia, depression, and disease.
VIVOZON
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2008-06-01
Status:
Active
Contact:
+1 609 269 9140
Email Addresses:
[email protected]
Technology used in webpage:
CrUX Dataset CrUX Top 10m
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Asklepion Pharmaceuticals
This company is a pharmaceutical development company.
Belite Bio
Belite Bio is a clinical stage biopharmaceutical drug development company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Ohm Oncology
Ohm Oncology is a drug development company
RareMed Solutions
RareMed Solutions is a pharmaceutical company.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-11-30 | SR Biotek | Vivozon investment in Corporate Round - SR Biotek | 2 B KRW |
More informations about "Vivozon"
VIVOZON
Vivozon US and Vivozon Canada are U.S. and Canadian subsidiaries of Vivozon, which are smoothly conducting global clinical trials and engaging in overseas cooperation for non …See details»
VIVOZON GROUP
Is what VIVOZON Pharmaceutical went through Global Innovative Drug Development Company Experts in new drug development are working together to ensure health, well-being, and …See details»
Vivozon - Crunchbase Investor Profile & Investments
Vivozon is working to extend its pipeline of second generation analgesic medication candidates, as well as its target combination of third analgesic …See details»
Vivozon’s Non-Opioid Pain Killer has been granted the …
CANTON, Mich. (November 8, 2018) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that the company has successfully …See details»
Organization: Vivozon Pharmaceutical - Cbonds.com
Organization: Vivozon Pharmaceutical Organization name. Vivozon Pharmaceutical Co Ltd , formerly Vivozon Healthcare, Ltd. ... Vivozon Pharmaceutical Co Ltd , formerly Vivozon …See details»
Vivozon 2025 Company Profile: Valuation, Funding & Investors
Vivozon General Information Description. Provider of drug development drug discovery services intended to treat pain using its unique ex-vivo screening technology. The company specializes …See details»
Vivozon - VentureRadar
Vivozon, Inc. is specialized in the discovery, development and commercialization of the small molecule drugs for the treatment of patients with the unmet CNS medical needs by applying …See details»
Interview: "Vivozon's oral non-opioid painkiller in …
Jan 14, 2025 In an interview with ChosunBiz at Vivozon’s office in Seoul on Jan. 7, Vivozon Chairman Lee Doo-hyun said, “Unafra is the world’s first multi-receptor-targeted non-opioid painkiller and the first non-opioid medication for …See details»
VIVOZON
Vivozon has established organization values and culture that promote the achievement of its mission and vision. We believe that continuous self-improvement and strive for excellence …See details»
Vivozon, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Vivozon, Inc. with its drug pipeline, therapeutic area, technology platform, 17 clinical trials, 1 news, and 3 literature, Disease Domain:Nervous System Diseases, Endocrinology and …See details»
FDA Grants Non-Opioid Analgesic VVZ-149 Fast Track …
Nov 9, 2018 Vivozon worked with the research organization MMS holdings to devise their regulatory strategy. “I am pleased that we were able to attain this Fast Track status and look forward to working with ...See details»
Vivozon's Non-Opioid Pain Killer has been granted the FDA's
Nov 8, 2018 MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that the company has successfully assisted Korea-based Vivozon Inc. in achieving a Fast …See details»
Vivozon head vows to finish developing non-narcotic pain killer
Sep 4, 2023 Vivozon Pharmaceutical’s Chairman Lee Doo-hyun, whose company is developing non-narcotic painkiller opiranserin (VVZ-149), has issued a strongly worded statement to its …See details»
Vivozon Company Profile - Office Locations, Competitors ... - Craft
Vivozon Summary. Company Summary. Overview. Vivozon is a company specialized in the discovery and commercialization of small molecule drugs. It is focused on the development of …See details»
VIVOZON
Novel drug candidates for pain and central nervous system diseases Global PIPELINE. more details Opiranserin (VVZ-149) injection is a first-in-class non-narcotic analgesic under …See details»
Vivozon, Inc. (Vivozon, Inc.) - 药物管线_专利_临床试验_投融营收_ …
了解Vivozon, Inc. (Vivozon, Inc.)公司的药物管线，治疗领域，技术平台，以及它的17项临床试验, 1篇新闻和3篇文献，疾病领域:神经系统疾病，内分泌与代谢疾病，技术平台:小分子化药，药 …See details»
Axxam enters into Drug Discovery Collaboration with Vivozon for …
Vivozon Inc. is specialized in the discovery, development and commercialization of the small molecule drugs for the treatment of patients with the unmet CNS medical needs by applying …See details»
今年第二款First in class镇痛药获批医药新闻-ByDrug-一站式医药资 …
Feb 21, 2025 近 日， 韩国 Vivozon Pharmaceutical 公司 宣布，其 开发的 非阿片类镇痛药 Unafra Inj （活性成分： Opiranserin HCl ）已获得 韩国 食品和药物安全部（ MFDS ） 的批准 …See details»
Evaluation of Safety, Pharmacokinetic, and Pharmacodynamic ...
Apr 15, 2025 Background VVZ-2471 is a dual-target compound that simultaneously inhibits both metabotropic glutamate receptor subtype 5 and serotonin receptor subtype 2A. Preclinical …See details»
VIVOZON
Vivozon is a global innovative drug development company established in 2008. We built an efficacy-based new drug discovery system that is clearly distinct from the existing new drug …See details»